Abuse Potential: Considerations for Rescheduling MDMA and Psychedelics
Can the meteoric rise of psychedelics and entactogens clear the legal hurdles of abuse potential assessment and rescheduling?
Legal Issues
Issues of Patient Safety and Ethical Violations in Psychedelic Therapy
MDMA-assisted therapy has been on the forefront of psychedelic research for years, but more recently patient safety concerns and research ethics have come into question.
DO-Why? The Story of DOI
The most important psychedelic research tool you’ve never heard of and why the DEA wants to schedule it.
COMPASS Patent Challenge Targets Crystallography Errors
Experts say COMPASS’ analysis overlooked one of the crystal forms present in their sample.
Why Aren’t Psychedelic Drugs Prohibited in the 2021 Tokyo Olympics?
The truth is that scientists don’t know enough about them. And research into any athletic-enhancing capabilities they may have is lacking.
Compassionate Use – Psychedelic Therapy for Those Who Can’t Wait
“Obviously, bureaucracy is not a human being. People have compassion. Bureaucracies don’t always have compassion.' -- Spencer Hawkswell
What Does Science Say About Maryland Rep. Andy Harris’s Opposition to Natural Psychedelics?
Scientific research does not support his statements that psychedelics are “very potent” and “very dangerous.”
Washington, DC Moves to Decriminalize Naturally Occurring Psychedelics
Decriminalize Nature DC is driving the effort to get the initiative on the November ballot.
UK Assessment Agency Rejects Spravato Ketamine Nasal Spray
UK Health Technology Assessment body raises questions over the clinical and cost-effectiveness of Spravato (esketamine).
Vermont Rep. Brian Cina Introduces Bill to Decriminalize Psilocybin, Peyote, Ayahuasca, and Kratom
If passed and signed by Governor Phil Scott, the law will go into effect July 1, 2020.